Ohbe Hiroyuki, Yamakawa Kazuma, Kudo Daisuke, Aso Shotaro, Matsui Hiroki, Fushimi Kiyohide, Yasunaga Hideo, Yatabe Tomoaki, Egi Moritoki, Ogura Hiroshi, Nishida Osamu, Kushimoto Shigeki
Department of Emergency and Critical Care Medicine, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Crit Care. 2025 Jun 3;29(1):225. doi: 10.1186/s13054-025-05482-9.
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock (J-SSCG) 2020 aimed to standardize sepsis care in Japan. However, the extent of their impact on clinical practice remains uncertain.
We conducted a nationwide retrospective cohort study using the Japanese Diagnosis Procedure Combination database between April 2018 and December 2021. Of the 118 clinical questions (CQs) in the J-SSCG 2020, we identified 26 recommendations to which adherence could be evaluated using patient-level data. We evaluated adherence trends before and after the guideline's publication using interrupted time series analysis and quantified hospital-level variation using intraclass correlation coefficients.
A total of 213,099 patients with sepsis from 791 hospitals were included. Adherence rates varied widely across CQs (range: 0.5-98.7%). Recommendations "against" interventions generally showed high adherence, whereas those "for" interventions exhibited lower and more variable adherence. After guideline publication, adherence increased by < 3% points for most CQs. Interrupted time series analysis demonstrated no abrupt or substantial changes, and statistically significant trends were modest (< 2% annually). Among the 26 CQs, 14 were consistent with J-SSCG 2016 and 12 were newly introduced in 2020; both groups showed similarly limited changes in adherence. Adjusted intraclass correlation coefficients exceeded 10% for 22 CQs, indicating persistent between-hospital variation, which remained unchanged after the guideline's release.
This nationwide study identified persistent evidence-practice gaps, minimal improvements in adherence after J-SSCG 2020, and substantial interhospital variation that remained unaltered. These findings underscore the challenges of implementing guidelines in practice and highlight the need to better understand contextual barriers to standardized sepsis care in Japan.
《2020年日本脓毒症和脓毒性休克管理临床实践指南》(J-SSCG)旨在规范日本的脓毒症护理。然而,其对临床实践的影响程度仍不确定。
我们利用日本诊断程序组合数据库在2018年4月至2021年12月期间进行了一项全国性回顾性队列研究。在J-SSCG 2020的118个临床问题(CQs)中,我们确定了26条建议,这些建议的依从性可通过患者层面的数据进行评估。我们使用中断时间序列分析评估了指南发布前后的依从性趋势,并使用组内相关系数对医院层面的差异进行了量化。
共纳入了来自791家医院的213,099例脓毒症患者。各CQs的依从率差异很大(范围:0.5-98.7%)。“反对”干预措施的建议总体上显示出较高的依从性,而“支持”干预措施的建议依从性较低且变化较大。指南发布后,大多数CQs的依从性提高了不到3个百分点。中断时间序列分析显示没有突然或实质性的变化,具有统计学意义的趋势较为温和(每年<2%)。在26个CQs中,14个与J-SSCG 2016一致,12个是2020年新引入的;两组的依从性变化同样有限。22个CQs的调整后组内相关系数超过10%,表明医院之间存在持续差异,指南发布后这种差异仍未改变。
这项全国性研究发现了持续存在的证据与实践之间的差距,J-SSCG 2020发布后依从性改善甚微,且医院之间的差异很大且未改变。这些发现强调了在实践中实施指南的挑战,并突出了更好地了解日本标准化脓毒症护理的背景障碍的必要性。